FPT Software Joins IT Giants to Kick Off Airbus’s Skywise Certified Partner Program
FPT Software on Wednesday signed an agreement with Airbus to become one of the first Airbus’s Skywise certified partners to drive digital collaboration across the global aviation industry. Other four companies handpicked by Airbus to kick off this program include Accenture, CapGemini, IBM, and Sopra Steria.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190619005409/en/
FPT Software and Airbus signed the agreement on the Skywise certified partner program at the sideline of the 53rd Paris Airshow on 19 June, 2019. (Photo: Business Wire)
Airbus’s selection criteria of certified partners include companies with global presence, familiarity with Skywise technology, high-quality human resources, existing business with airlines, and existing business relationships with the European aircraft maker.
According to Airbus, the Skywise certified partners will benefit from dedicated training and certification to help aviation players develop more robust, richer applications within the open data platform. They will have access to its own working space on Skywise and to additional platform features.
Skywise, “the beating heart of aviation” as Airbus called it, is a digital, hyper-connected and secure data platform that enables users to optimise and predict everything from engineering and maintenance to flight operations. Launched at the Paris Airshow in mid-2017, it has grown to become a platform of reference used by 80 aviation players and is expected to welcome dozens more onboard by the end of this year.
“The Industrial Revolution 4.0 of the aviation sector has been realized by the global leading aircraft manufacturer Airbus through its Skywise platform. FPT Software is proud to stand alongside IBM, Accenture, Capgemini, and Sopra Steria to shape the future of aviation. Our software engineers are working round the clock to develop and deploy deploy Skywise applications for airliners around the world applications", FPT Software Chairman Hoang Nam Tien affirmed.
FPT Software has been a trusted partner of Airbus since 2017 as the two companies signed a Letter of Intent to strengthen the development of Skywise ecosystem in Asia. Over the past two years, the company has helped Airbus to gather, standardize, and integrate data of more than 30 airliners to the Skywise platform. According to Mr. Mathew Evans, Airbus Director of Global Skywise Project, the two companies have collaborated comprehensively and extensively. “Skywise is a global aviation industry project”, he said. “We are in this together not only for the short term but also set for a long future ahead”.
After two decades of leading Southeast Asia in IT services, FPT Software has recently decided to shift its focus onto digital transformation, looking to be named in the world’s Top 50 digital transformation service provider within ten years. The company has partnered with major airliners in Europe, the United States, Vietnam to transform the global aviation industry through disruptive digital services and solutions.
About FPT Software
FPT Software is a subsidiary of FPT Corporation – a global leading II services provider headquartered in Vietnam with nearly US$2 billion in revenue and 33,000 employees. Qualified with CMMI Level 5 v1.3 & ISO 27001, FPT Software delivers world-class services in Analytics, IoT, Mobility, Cloud, Embedded System, QA testing, Legacy Migration, Package Implementation, Application Service, and BPO services globally from delivery centers across the United States, Japan, Europe, Australia, Vietnam and the Asia Pacific. The company has served over 600 customers worldwide, a hundred of which are Fortune 500 companies in the industries of Aerospace & Aviation, Automotive, Banking and Finance, Communications, Media and Services, Logistics & Transportation, Utilities, Consumer Packaged Goods, Healthcare, Manufacturing, Public sector, Technology and more. For more information, please visit www.fpt-software.com.
About Airbus
Airbus is a global leader in aeronautics, space and related services. In 2018 it generated revenues of € 64 billion and employed a workforce of around 134,000. Airbus offers the most comprehensive range of passenger airliners. Airbus is also a European leader providing tanker, combat, transport and mission aircraft, as well as one of the world’s leading space companies. In helicopters, Airbus provides the most efficient civil and military rotorcraft solutions worldwide.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190619005409/en/
Contact information
For inquiries, please contact:
Hue LE
+848 6686 7745
hueltm@fsoft.com.vn
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology27.4.2024 02:09:00 CEST | Press release
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines,today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the integration of key individuals of GanNA Bio into the ReNAgade ecosystem. GanNA founders Carolyn Bertozzi, Ph.D., and Richard D. Cummings, Ph.D, will now serve as advisors to ReNAgade. “ReNAgade will continue to benefit tremendously from GanNA’s promising work in developing extra-hepatic delivery technology that helps expand the breadth and potential of our own RNA medicines,” said Brian Goodman, Co-founder of ReNAgade. “Delivery is foundational to ReNAgade’s mission to overcome the current limitations of RNA medicines. We believe the technology developed within GanNA will help further solidify ReNAgade’s leadership position as we continue advancing our unique, integrated therapeutic platform.” Formed in 2021 and invested in by ReNAgade, GanNA Bio har
HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 22:06:00 CEST | Press release
HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY
Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 18:03:00 CEST | Press release
Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio
Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)
Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release
Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com